CDK2 억제제 및 그의 사용 방법

본 개시내용은 CDK2의 억제, 및 CDK2 관련 질환 및 장애의 치료를 위한 화합물, 그의 조성물, 및 그의 사용 방법을 제공한다. The present disclosure provides compounds according to Formula I or a pharmaceutically acceptable salt thereof:wherein each variable is as defined and described herein, compositions thereof, and methods of using the same for...

Full description

Saved in:
Bibliographic Details
Main Authors BLAISDELL THOMAS P, KIRMAN LOUISE CLARE, MICHOWSKI WOJTEK, RIPPER JUSTIN, SCHWARTZ CARL ERIC, FEUTRILL JOHN, SHERRILL JOHN PAUL, PORTER DALE A. JR
Format Patent
LanguageKorean
Published 11.10.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:본 개시내용은 CDK2의 억제, 및 CDK2 관련 질환 및 장애의 치료를 위한 화합물, 그의 조성물, 및 그의 사용 방법을 제공한다. The present disclosure provides compounds according to Formula I or a pharmaceutically acceptable salt thereof:wherein each variable is as defined and described herein, compositions thereof, and methods of using the same for the inhibition of CDK2, and the treatment of CDK2 related diseases and disorders.
Bibliography:Application Number: KR20237029169